TrialDiabetologia2018

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.

Paul Welsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.